, Volume 236, Issue 2, pp 741–752 | Cite as

Ameliorative effect of fisetin against lipopolysaccharide and restraint stress-induced behavioral deficits via modulation of NF-κB and IDO-1

  • Priyansha Choubey
  • Mohit Kwatra
  • Surya Narayan Pandey
  • Dinesh Kumar
  • Durgesh Kumar Dwivedi
  • Prabha Rajput
  • Abhishek Mishra
  • Mangala Lahkar
  • Ashok JangraEmail author
Original Investigation



Fisetin, a plant active polyphenol, is well known for its antioxidant and free radical scavenging activities. The present study was designed to explore the detailed molecular mechanism underlying its neuroprotective effects.


The young male mice were either administered a single dose of lipopolysaccharide (0.83 mg/kg) or subjected to restraint stress (6 h per day for 28 days) to induce behavioral deficits in different groups. Fisetin (15 mg/kg) was orally administered for the last 14 days of the study.


Lipopolysaccharide (LPS) as well as restraint stress (RS) exposure caused behavioral alterations (anxiety and depressive-like behavior). Gene expression analysis showed upregulation of nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) and indoleamine 2,3-dioxygenase (IDO)-1 gene expression along with downregulation of Nrf-2 (nuclear factor erythroid 2-related factor 2), HO-1 (heme oxygenase-1), and ChAT (choline acetyltransferase) gene expression level in RS and RS+LPS groups. Fisetin administration significantly ameliorated behavioral and neurochemical deficits in LPS, RS, and RS+LPS groups.


These findings clearly indicated that fisetin administration improved behavioral functions and suppressed the NF-κB and IDO-1 (indoleamine 2,3-dioxygenase) activation along with their antioxidant effect, suggesting fisetin as an intriguing nutraceutical for the management of inflammation-associated neurological disorders.


Fisetin Hippocampus Inflammation Lipopolysaccharide Restrained stress 



The authors are also grateful to SBT Hub, College of Veterinary Sciences, Guwahati for providing technical support.

Funding information

Authors would like to thank the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati for financial assistance.

Compliance with ethical standards

All the experiments were carried out in accordance with the regulation of Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India guidelines.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Ahmed SMU, Luo L, Namani A et al (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta - Mol Basis Dis 1863:585–597. CrossRefGoogle Scholar
  2. André C, Dinel A-L, Ferreira G, Layé S, Castanon N (2014) Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2, 3-dioxygenase activation. Brain Behav Immun 41:10–21CrossRefGoogle Scholar
  3. Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64:238–258. CrossRefGoogle Scholar
  4. Barbosa Filho JM, Medeiros KCP, de FFM DM et al (2006) Natural products inhibitors of the enzyme acetylcholinesterase. Rev Bras Farmacogn 16:258–285CrossRefGoogle Scholar
  5. Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11:1164–1178. CrossRefGoogle Scholar
  6. Beutler E (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888Google Scholar
  7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefGoogle Scholar
  8. Breese GR, Knapp DJ, Overstreet DH, Navarro M, Wills TA, Angel RA (2008) Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 33:867–876CrossRefGoogle Scholar
  9. Capiotti KM, De Moraes DA, Menezes FP et al (2014) Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio). Behav Brain Res 274:319–325. CrossRefGoogle Scholar
  10. Chang H-A, Wang Y-H, Tung C-S, Yeh CB, Liu YP (2016) 7,8-Dihydroxyflavone, a tropomyosin-kinase related receptor B agonist, produces fast-onset antidepressant-like effects in rats exposed to chronic mild stress. Psychiatry Investig 13:531–540. CrossRefGoogle Scholar
  11. Conrad CD (2008) Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci 19:395–412CrossRefGoogle Scholar
  12. Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, Quehenberger O, Maher P (2014) Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice. Aging Cell 13:379–390CrossRefGoogle Scholar
  13. Dwivedi DK, Jena GB (2018) Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation. Naunyn Schmiedebergs Arch Pharmacol 1–18Google Scholar
  14. Feng G, Jiang Z, Sun B, Fu J, Li TZ (2016) Fisetin alleviates lipopolysaccharide-induced acute lung injury via TLR4-mediated NF-κB signaling pathway in rats. Inflammation 39:148–157CrossRefGoogle Scholar
  15. Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H, Seishima M (2006) The signal transducer and activator of transcription 1α and interferon regulatory factor 1 are not essential for the induction of indoleamine 2, 3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-κB. J Biochem 139:655–662CrossRefGoogle Scholar
  16. German-Ponciano LJ, Rosas-Sánchez GU, Rivadeneyra-Domínguez E, Rodríguez-Landa JF (2018) Advances in the preclinical study of some flavonoids as potential antidepressant agents. Scientifica (Cairo) 2018Google Scholar
  17. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138CrossRefGoogle Scholar
  18. Guan Z, Fang J (2006) Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun 20:64–71CrossRefGoogle Scholar
  19. Guo Y, Sun J, Li T, Zhang Q, Bu S, Wang Q, Lai D (2017) Melatonin ameliorates restraint stress-induced oxidative stress and apoptosis in testicular cells via NF-kappaB/iNOS and Nrf2/ HO-1 signaling pathway. Sci Rep 7:9599. CrossRefGoogle Scholar
  20. Gupta SC, Prasad S, Aggarwal BB (2016) Anti-inflammatory nutraceuticals and chronic diseases. SpringerGoogle Scholar
  21. Gutierrez-Merino C, Lopez-Sanchez C, Lagoa R, K. Samhan-Arias A, Bueno C, Garcia-Martinez V (2011) Neuroprotective actions of flavonoids. Curr Med Chem 18:1195–1212CrossRefGoogle Scholar
  22. Heisler JM, O’Connor JC (2015) Indoleamine 2, 3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory. Brain Behav Immun 50:115–124CrossRefGoogle Scholar
  23. Huang G-B, Zhao T, Muna SS, Bagalkot TR, Jin HM, Chae HJ, Chung YC (2013) Effects of chronic social defeat stress on behaviour, endoplasmic reticulum proteins and choline acetyltransferase in adolescent mice. Int J Neuropsychopharmacol 16:1635–1647CrossRefGoogle Scholar
  24. Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP (2008) Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging 29:1744–1753CrossRefGoogle Scholar
  25. Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST (2003) Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer’s neuropathology. J Alzheimers Dis 5:39–48CrossRefGoogle Scholar
  26. Jangra A, Dwivedi S, Sriram CS, Gurjar SS, Kwatra M, Sulakhiya K, Baruah CC, Lahkar M (2016a) Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice. Eur J Pharmacol 770:25–32CrossRefGoogle Scholar
  27. Jangra A, Kwatra M, Singh T, Pant R, Kushwah P, Sharma Y, Saroha B, Datusalia AK, Bezbaruah BK (2016b) Piperine augments the protective effect of curcumin against lipopolysaccharide-induced neurobehavioral and neurochemical deficits in mice. Inflammation 39:1025–1038CrossRefGoogle Scholar
  28. Jangra A, Lukhi MM, Sulakhiya K, Baruah CC, Lahkar M (2014) Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. Eur J Pharmacol 740:337–345CrossRefGoogle Scholar
  29. Jangra A, Sriram CS, Dwivedi S, Gurjar SS, Hussain MI, Borah P, Lahkar M (2017) Sodium phenylbutyrate and edaravone abrogate chronic restraint stress-induced behavioral deficits: implication of oxido-nitrosative, endoplasmic reticulum stress cascade, and neuroinflammation. Cell Mol Neurobiol 37:65–81CrossRefGoogle Scholar
  30. Jangra A, Sriram CS, Lahkar M (2016c) Lipopolysaccharide-induced behavioral alterations are alleviated by sodium phenylbutyrate via attenuation of oxidative stress and neuroinflammatory cascade. Inflammation 39:1441–1452CrossRefGoogle Scholar
  31. Kasbe P, Jangra A, Lahkar M (2015) Mangiferin ameliorates aluminium chloride-induced cognitive dysfunction via alleviation of hippocampal oxido-nitrosative stress, proinflammatory cytokines and acetylcholinesterase level. J Trace Elem Med Biol 31:107–112CrossRefGoogle Scholar
  32. Lacosta S, Merali Z, Anisman H (1999) Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res 818:291–303CrossRefGoogle Scholar
  33. Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine:42–145, 151.
  34. Maher P (2009) Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes Nutr 4:297–307CrossRefGoogle Scholar
  35. Maher P (2015) Fisetin acts on multiple pathways to reduce the impact of age and disease on CNS function. Front Biosci (Schol Ed) 7:58–82CrossRefGoogle Scholar
  36. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851–858CrossRefGoogle Scholar
  37. Nunes-Tavares N, Santos LE, Stutz B, Brito-Moreira J, Klein WL, Ferreira ST, de Mello FG (2012) Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-beta peptide oligomers. J Biol Chem 287:19377–19385. CrossRefGoogle Scholar
  38. O’Connor JC, Lawson MA, Andre C et al (2009a) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511–522. CrossRefGoogle Scholar
  39. O’Connor JC, Lawson MA, André C et al (2009b) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511–522. CrossRefGoogle Scholar
  40. O’Connor JC, Lawson MA, André C et al (2009c) Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182:3202–3212CrossRefGoogle Scholar
  41. O’Keane V (2000) Evolving model of depression as an expression of multiple interacting risk factors. Br J Psychiatry 177:482–483. CrossRefGoogle Scholar
  42. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefGoogle Scholar
  43. Ohta Y, Kubo H, Yashiro K, Ohashi K, Tsuzuki Y, Wada N, Yamamoto Y, Saito K (2017) Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues. J Physiol Sci 67:361–372. CrossRefGoogle Scholar
  44. Pant R, Jangra A, Kwatra M, Singh T, Kushwah P, Bezbaruah BK, Gurjar SS, Phukan S (2017) Cognitive deficits induced by combined exposure of stress and alcohol mediated through oxidative stress-PARP pathway in the hippocampus. Neurosci Lett 653:208–214CrossRefGoogle Scholar
  45. Park H-J, Shim HS, Kim H, Kim KS, Lee H, Hahm DH, Shim I (2010) Effects of glycyrrhizae radix on repeated restraint stress-induced neurochemical and behavioral responses. Korean J Physiol Pharmacol Off J Korean Physiol Soc Korean Soc Pharmacol 14:371–376. CrossRefGoogle Scholar
  46. Prakash D, Gopinath K, Sudhandiran G (2013) Fisetin enhances behavioral performances and attenuates reactive gliosis and inflammation during aluminum chloride-induced neurotoxicity. NeuroMolecular Med 15:192–208CrossRefGoogle Scholar
  47. Prakash D, Sudhandiran G (2015) Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain. J Nutr Biochem 26:1527–1539CrossRefGoogle Scholar
  48. Rajput P, Jangra A, Kwatra M, Mishra A, Lahkar M (2017) Alcohol aggravates stress-induced cognitive deficits and hippocampal neurotoxicity: protective effect of melatonin. Biomed Pharmacother 91:457–466CrossRefGoogle Scholar
  49. Rinne JO, Kaasinen V, Järvenpää T et al (2003) Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer’s disease. J Neurol Neurosurg & Psychiatry 74:113 LP–113115CrossRefGoogle Scholar
  50. Sahu BD, Kalvala AK, Koneru M, Mahesh Kumar J, Kuncha M, Rachamalla SS, Sistla R (2014) Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence. PLoS One 9:e105070CrossRefGoogle Scholar
  51. Sahu BD, Kumar JM, Sistla R (2016) Fisetin, a dietary flavonoid, ameliorates experimental colitis in mice: relevance of NF-κB signaling. J Nutr Biochem 28:171–182CrossRefGoogle Scholar
  52. Segerstrom SC, Miller GE (2004) Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130:601–630CrossRefGoogle Scholar
  53. Shih R-H, Wang C-Y, Yang C-M (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77CrossRefGoogle Scholar
  54. Sjöholm L, Lavebratt C, Forsell Y (2009) A multifactorial developmental model for the etiology of major depression in a population-based sample. J Affect Disord 113:66–76CrossRefGoogle Scholar
  55. Solanki I, Parihar P, Mansuri ML, Parihar MS (2015) Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr 6:64–72. CrossRefGoogle Scholar
  56. Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M (2002) Fluoxetine treatment of depressed patients with comorbid anxiety disorders. J Psychopharmacol 16:215–219CrossRefGoogle Scholar
  57. Sriram CS, Jangra A, Gurjar SS, Hussain MI, Borah P, Lahkar M, Mohan P, Bezbaruah BK (2015) Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice. Pharmacol Biochem Behav 133:83–91CrossRefGoogle Scholar
  58. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370CrossRefGoogle Scholar
  59. Sulakhiya K, Kumar P, Jangra A, Dwivedi S, Hazarika NK, Baruah CC, Lahkar M (2014) Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice. Eur J Pharmacol 744:124–131CrossRefGoogle Scholar
  60. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Toné S, Senba E (1997) Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28:103–110CrossRefGoogle Scholar
  61. Vijayaraghavan S, Karami A, Aeinehband S, Behbahani H, Grandien A, Nilsson B, Ekdahl KN, Lindblom RPF, Piehl F, Darreh-Shori T (2013) Regulated extracellular choline acetyltransferase activity—the plausible missing link of the distant action of acetylcholine in the cholinergic anti-inflammatory pathway. PLoS One 8:e65936. CrossRefGoogle Scholar
  62. Wahba ZZ, Soliman KFA (1992) Effect of stress on choline acetyltransferase activity of the brain and the adrenal of the rat. Experientia 48:265–268CrossRefGoogle Scholar
  63. Wang Y, Lawson MA, Dantzer R, Kelley KW (2010) LPS-induced indoleamine 2, 3-dioxygenase is regulated in an interferon-γ-independent manner by a JNK signaling pathway in primary murine microglia. Brain Behav Immun 24:201–209CrossRefGoogle Scholar
  64. Wang Y, Xu J, Liu Y, et al (2018) TLR4-NF-κB signal involved in depressive-like behaviors and cytokine expression of frontal cortex and hippocampus in stressed C57BL/6 and ob/ob mice. Neural Plast 2018:Google Scholar
  65. Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans 43:621–626. CrossRefGoogle Scholar
  66. WHO (2018) Depression key factsGoogle Scholar
  67. Wichers MC, Maes M (2004) The role of indoleamine 2, 3-dioxygenase (IDO) in the pathophysiology of interferon-α-induced depression. J Psychiatry Neurosci 29:11Google Scholar
  68. Wu P-Y, Lyu J-L, Liu Y-J, Chien TY, Hsu HC, Wen KC, Chiang HM (2017) Fisetin regulates Nrf2 expression and the inflammation-related signaling pathway to prevent UVB-induced skin damage in hairless mice. Int J Mol Sci 18:2118CrossRefGoogle Scholar
  69. Xu W, Zheng D, Liu Y, Li J, Yang L, Shang X (2017) Glaucocalyxin B alleviates lipopolysaccharide-induced Parkinson’s disease by inhibiting TLR/NF-kappaB and activating Nrf2/HO-1 pathway. Cell Physiol Biochem 44:2091–2104. CrossRefGoogle Scholar
  70. Yu X, Jiang X, Zhang X, Chen Z, Xu L, Chen L, Wang G, Pan J (2016) The effects of fisetin on lipopolysaccharide-induced depressive-like behavior in mice. Metab Brain Dis 31:1011–1021CrossRefGoogle Scholar
  71. Zhang J, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Hashimoto K (2015) Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacology 232:4325–4335. CrossRefGoogle Scholar
  72. Zhang M-W, Zhang S-F, Li Z-H, Han F (2016) 7,8-Dihydroxyflavone reverses the depressive symptoms in mouse chronic mild stress. Neurosci Lett 635:33–38. CrossRefGoogle Scholar
  73. Zhao X, Wang C, Cui W-G, Ma Q, Zhou WH (2015a) Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic system. Sci Rep 5:9043. CrossRefGoogle Scholar
  74. Zhao Y, Zhang Y, Pan F (2015b) The effects of EGb761 on lipopolysaccharide-induced depressive-like behaviour in C57BL/6J mice. Cent J Immunol 40:11–17. CrossRefGoogle Scholar
  75. Zhen L, Zhu J, Zhao X, Huang W, An Y, Li S, du X, Lin M, Wang Q, Xu Y, Pan J (2012) The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behav Brain Res 228:359–366. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Priyansha Choubey
    • 1
  • Mohit Kwatra
    • 1
  • Surya Narayan Pandey
    • 1
  • Dinesh Kumar
    • 1
  • Durgesh Kumar Dwivedi
    • 1
  • Prabha Rajput
    • 1
  • Abhishek Mishra
    • 2
  • Mangala Lahkar
    • 3
  • Ashok Jangra
    • 1
    • 4
    Email author
  1. 1.Department of Pharmacology and ToxicologyNational Institute of Pharmaceutical Education and Research (NIPER)GuwahatiIndia
  2. 2.Department of PharmacologyPostgraduate Institute of Medical Education and Research (PGIMER)ChandigarhIndia
  3. 3.Department of PharmacologyGauhati Medical CollegeGuwahatiIndia
  4. 4.Department of Pharmacology, KIET School of PharmacyKIET Group of InstitutionsGhaziabadIndia

Personalised recommendations